Objective: To study lipid profi le in patients of subclinical hypothyroidism and compare the same with matched controls. Materials and Methods: This single exposure observational study was conducted from June 2010 to March 2011 at our department of Biochemistry. Thirty patients with subclinical hypothyroidism were selected after careful exclusion; lipid profi le was compared with matched controls. Statistical analysis was done with Student's t test. All values were expressed as mean ± SEM, where value of P ≤ 0.05 was considered statistically signifi cant. Results: Between the two groups (group I -controls vs. group II -cases), the values were as follows: Mean serum total T 3 value was 115.03 ± 28.22 ng/dl vs. 107.13 ± 35.26 ng/dl (P = 0.3474); mean total T 4 was 7.0787 ± 1.6952 μg/dl vs. 6.8633 ± 1.3106 μg/dl (P = 0.532); mean TSH was 3.1730 ± 1.2772 μIU/ml vs. 9.7607 ± 4.1853 μIU/ml (P < 0.0001). Lipid profi le pattern (group I vs. group II) was as follows: Mean total cholesterol (TC) 127.50 ± 7.18 mg/dl vs. 163.07 ± 41.32 mg/dl (P < 0.0001), mean triglycerides (TG) is 135.67 ± 13.84 mg/dl vs. 147.90 ± 66.27 mg/ dl (P = 0.3231), low-density lipoprotein (LDL)-cholesterol is 61.17 ± 7.60 mg/dl vs. 99.83 ± 32.24 mg/dl (P < 0.0001), high-density lipoprotein (HDL)-cholesterol 39.13 ± 6.66 mg/dl vs. 35.27 ± 8.63 mg/dl (P = 0.0701), very low-density lipoprotein (VLDL) levels are 33.533 ± 14.375 mg/dl vs. 31.077 ± 14.202 mg/dl (P = 0.5235). Conclusion: Subclinical hypothyroidism is associated with increased serum total cholesterol and LDL-Cholesterol levels. Therefore, there is a potential association between Subclinical hypothyroidism and atherosclerosis.
INTRODUCTION
Subclinical hypothyroidism (mild hypothyroidism or biochemical hypothyroidism) is defined as normal serum Total T 4 (TT 4 )/free T 4 (FT 4 ) and Total T 3 (TT 3 )/free T 3 (FT 3 ) levels in the presence of elevated serum thyroid stimulating hormone (TSH) levels. [1] [2] [3] The prevalence of this condition in adults is 4-10%. It is higher in women than in men and increases with age, reaching a peak of 21% in women and 16% in men over 74 years of age. [4, 5] The etiology and nature of SCH are the same as in overt hypothyroidism.
The symptoms pertaining to SCH are nonspecific and depend on individual sensitivity to circulating hormones or tissue level of hormones. [6] Though SCH can affect various organ systems, the cardiovascular system is the major target. In SCH patients, the cardiac hemodynamic changes reported are increased systemic vascular resistance (SVR), diastolic dysfunction, and reduced systolic function that are similar to those observed in overt hypothyroidism. [7] SCH could impair vascular function by inducing an increase in SVR and arterial stiffness and by altering endothelial function and thereby potentially increasing the risk of atherosclerosis and coronary artery disease. [8, 9] Moreover, an inconsistent change to atherogenic lipids may also add to the cardiovascular risks. [10] The epidemiological data about cardiovascular risk in SCH is controversial, as some of the studies have shown an increase in myocardial infarction [11] and heart failure, [12] whereas others did not find any increase in cardiovascular disease or mortality. [13] This discrepancy could be due to differences in study population (viz. age, sex), TSH range that defines SCH, methods of evaluation of cardiovascular disease, and differences in adjustments for known risk factors for cardiovascular disease.
As SCH is being diagnosed more frequently in young and middle-aged people, there is a need to know the effect of SCH on cardiovascular risk factors in young South Indians. Therefore, the objective of this study is to analyze the relation between SCH and serum lipid parameters in this subgroup. Patients with history of diabetes mellitus, coronary heart disease, pregnancy, obesity, post-menopausal status, acute illness, and other disorders that affect lipid metabolism were excluded. Patients who were exposed to thyroid hormone therapy or lipid-lowering agent in the past 6 months were also excluded.
MATERIALS AND METHODS
Thirty patients (27 females and 3 males) were included in the present study and thirty age-and sex-matched and regularly menstruating healthy controls, who were evaluated for Thyroid Function test were randomly recruited from staff and volunteers. Informed consent was obtained from both cases and controls; this study was approved by the ethical committee.
Methodology
Blood samples were drawn at 08:00 h after an overnight fast in a sterile bottle. Serum was separated for the estimation of serum TSH, TT 3 , TT 4 , and total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), which were derived from TC and TG, using Friedwald's Formula [LDL = TC -(HDL + TG/5)], [7, 9] Very low-density lipoprotein (VLDL) derived from TG. T 3 , T 4 , and TSH were estimated by using quantitative solid phase enzyme-linked immune sorbent assay (ELISA), whereas TC was estimated with photometric determination according to the CHOD PAP method; TG and HDL were estimated by using the enzymatic colorimetric method. Statistical analysis was done with the Student t test, where all values were expressed as mean ± SEM, and value of P ≤ 0.05 was considered statistically significant.
RESULTS
As SCH is defined as elevated levels of TSH with respect to normal levels of T 3 and T 4 ; hence, T 3 and T 4 levels were matched with a group I (controls) and group II (cases).
In group I individuals, the mean serum T 3 level was 115.03 ± 28.22 ng/dl. In group II individuals, the mean serum T 3 level is 107.13 ± 35.26 ng/dl (P = 0.3474).
In group I individuals, the mean serum T 4 level is 7.0787 ± 1.6952 μg/dl. In group II individuals, the mean serum T 4 level is 6.8633 ± 1.3106 μg/dl (P = 0.5352).
The levels of TSH are significantly higher in group II (9.7607 ± 4.1853 μIU/ml) compared to group I (3.1730 ± 1.2772 μIU/ml), P < 0.0001, which is considered to be statistically significant.
There is a significant increase in the serum TC level in group II individuals (163.07 ± 41.32 mg/dl) when compared to group I (127.50 ± 7.18 mg/dl), P < 0.0001; this difference is considered to be statistically significant.
There is also a significant increase in serum LDL-Cholesterol in group II individuals (99.83 ± 32.24 mg/dl) when compared to group I individuals (61.17 ± 7.60), P < 0.0001, which is statistically significant.
There is no significant difference in serum HDL-Cholesterol among the group I (39.13 ± 6.66 mg/dl) and group II (35.27 ± 8.63 mg/dl), P = 0.0701, which is not quite statistically significant.
In group I individuals, the mean serum TG is 135.67 ± 13.84 mg/dl. In group II individuals, the levels are 147.90 ± 66.27, P = 0.3231, which is not statistically significant. A small increase in serum TG level in group II compared to group I may be noted [ Table 1 and Figure 1 ]. There is no significant difference in serum VLDL levels among the group I (33.533 ± 14.375) and group II (31.077 ± 14.202) P = 0.5235, which is statistically insignificant.
DISCUSSION
The present study was conducted among the subclinical hypothyroid patients attending various tertiary care hospitals. The possible correlation between SCH and serum concentrations of lipids was evaluated.
The pathophysiology of dyslipidemia in hypothyroidism is not exactly known. However, the proposed mechanisms for dyslipidemia in hypothyroidism are as follows:
• Primary accumulation of LDL cholesterol due to reduction in the number of cell surface receptors for LDL results in decreased catabolism of LDL [14] • Diminished secretion of cholesterol into bile has been demonstrated in hypothyroid rats [15] • Reduced cholesteryl ester transfer (the net transfer of cholesterol from HDL to LDL and VLDL) in hypothyroidism may minimize the increase in serum LDL cholesterol concentrations [16] • Reduced lipoprotein lipase activity is responsible for the development of hypertriglyceridemia in hypothyroidism although the rate of TG synthesis is normal. [17] The relationship between subclinical hypothyroidism and serum lipids remains controversial. [18] In several cross-sectional studies, subclinical hypothyroidism was found to be associated with a variable and somewhat inconsistent increase in TC and in LDL-C, [5, 19, 20] higher plasma oxidized LDL-C levels, [21] and inconsistent changes in serum levels of HDL-C. [22] As expected, the lipid pattern is more abnormal in individuals with serum TSH greater than 10 mIU/liter, [23] and it is more deranged in those who smoke. [21] In our study, TC and LDL-C were significantly increased and non-significantly elevated serum TG levels were seen in group II subjects when compared to group I. There was no significant difference in the levels of HDL-C and VLDL-C in two groups. These results correlated well with the Colorado thyroid disease prevalence study, which showed that TC and LDL-C in SCH were significantly higher than that in euthyroidism but TG and HDL-C were not significantly different. [24] Whereas the results are consistent with few of the available Indian studies in terms of LDL, TC levels and not with TG and VLDL levels. [25, 26] These differences could be a result of our small sample size, difference in age, ethnicity, and dietary habits of selected samples.
Limita ons
The sample size of this study was small. We did not carry out anti-TPO antibody or serum lipoprotein (a) test in our patients. T 3 , T 4 , and TSH were estimated using ELISA as new generation assay was not available at our centre, and we did not observed the effect of thyroxine therapy on this lipid profile.
CONCLUSION
Subclinical hypothyroidism is associated with increased serum TC and LDL-C levels. Therefore, there is a potential association between subclinical hypothyroidism and atherosclerosis. Larger studies are needed to prove this association in Indian patients. 
